Toripalimab with chemotherapy for untreated recurrent or metastatic nasopharyngeal cancer [ID6406]

In development
Reference number: GID-TA11341
Expected publication date: 02 December 2026

Register as a stakeholder

Documents

Documents created during the development process.

Invitation to participate

Final scope (PDF 131 KB)

Published:

26 January 2026
Final stakeholder list (PDF 134 KB)

Published:

26 January 2026
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 191 KB)

Published:

26 January 2026
Equality impact assessment (scoping) (PDF 101 KB)

Published:

26 January 2026

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6406

Draft scope post referral (PDF 171 KB)

Published:

13 November 2025
Provisional stakeholder list post referral (PDF 148 KB)

Published:

13 November 2025

Notes

Please note that following on from advice received from the company, further information regarding the timelines for this appraisal will be available in due course. In the meantime, NICE will continue to monitor the situation and will provide an update as and when the situation changes.